Michael Woudenberg
2024
In 2024, Michael Woudenberg earned a total compensation of $349.2K as Chief Operating Officer at InMed Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
| Bonus | $54,400 |
|---|---|
| Option Awards | $22,800 |
| Salary | $272,000 |
| Total | $349,200 |
Woudenberg received $272K in salary, accounting for 78% of the total pay in 2024.
Woudenberg also received $54.4K in bonus and $22.8K in option awards.
Rankings
In 2024, Michael Woudenberg's compensation ranked 117th out of 152 executives tracked by ExecPay. In other words, Woudenberg earned more than 23.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 117 out of 152 | 23rd |
Division Manufacturing | 51 out of 66 | 23rd |
Major group Chemicals And Allied Products | 19 out of 26 | 27th |
Industry group Drugs | 19 out of 26 | 27th |
Industry Pharmaceutical Preparations | 17 out of 23 | 26th |
Source: SEC filing on October 28, 2024.
Woudenberg's colleagues
We found five more compensation records of executives working with Michael Woudenberg at InMed Pharmaceuticals in 2024.
2024
Eric Adams
InMed Pharmaceuticals
Chief Executive Officer
2024
Eric Hsu
InMed Pharmaceuticals
Senior Vice President, Preclinical Research & Development
2024
Alexandra Mancini
InMed Pharmaceuticals
Senior Vice President, Clinical & Regulatory Affairs
2024
Netta Jagpal
InMed Pharmaceuticals
Chief Financial Officer
2024
Jonathan Tegge
InMed Pharmaceuticals